about
Ambulatory heart rate range predicts mode-specific mortality and hospitalisation in chronic heart failure.Performance of 2014 NICE defibrillator implantation guidelines in heart failure risk stratification.Effects of Vitamin D on Cardiac Function in Patients With Chronic HF: The VINDICATE Study.Patients with long-term permanent pacemakers have a high prevalence of left ventricular dysfunction.Chronotropic Incompetence Does Not Limit Exercise Capacity in Chronic Heart Failure.Cardiac resynchronization therapy in pacemaker-dependent patients with left ventricular dysfunction.Cardiac resynchronization therapy outcomes in patients with chronic heart failure: cardiac resynchronization therapy with pacemaker versus cardiac resynchronization therapy with defibrillator.Response to (resynchronization) therapy in chronic heart failure: time for a different approach.Mortality Reduction Associated With β-Adrenoceptor Inhibition in Chronic Heart Failure Is Greater in Patients With Diabetes.Devices in heart failure; diagnosis, detection and disease modification.Rate-Response Programming Tailored to the Force-Frequency Relationship Improves Exercise Tolerance in Chronic Heart Failure.Calcium, phosphate and calcium phosphate product are markers of outcome in patients with chronic heart failure.Pacing-associated left ventricular dysfunction? Think reprogramming first!Septal pacing: still no clarity?Optimisation of pacemaker therapy for cardiac functionReply
P50
Q36577192-53598817-AF9C-414B-B43C-3B7F125ACE35Q36859699-4259375E-C284-4CB7-9F92-A0B496D3A4A3Q36968934-BC82B313-89DE-4F9D-B2D2-BC0E3249A6B0Q38224672-03C98234-CC3F-4A7F-B0FF-AD2ADC90DB5BQ39832349-6BF8812D-EEFE-40B3-9A00-069E847D318EQ45282222-4372FBD7-497A-4EB4-AA96-3CABFACDC7C4Q47768449-73B377C7-584A-453F-B017-AF740C4AAEE7Q48090064-9FDDDFF5-0E12-4512-AF5C-C29F7C8C8809Q48236335-FFA82D55-72A0-4E8F-9D63-E88868B6ED59Q48516435-DA925D8E-3E61-4472-AD82-A36FA3A68D0BQ49954439-44F07309-B7FA-4FF0-88DE-FD18425F94C2Q52840100-18A2709C-A750-48FC-9624-8218ABFF1547Q52840467-54940A57-6270-4F28-BE66-6845A6C9504DQ52840703-F6B58391-62A4-4893-9B7E-6C8C3B71B2A2Q56649952-07CAE36D-39F9-40C7-A190-2F47E3BD151EQ58418505-130ECE0A-EBA5-49E6-8F8A-5310662942E5
P50
description
researcher
@en
researcher
@en-gb
wetenschapper
@nl
հետազոտող
@hy
name
John Gierula
@ast
John Gierula
@en
John Gierula
@en-gb
John Gierula
@es
John Gierula
@nl
John Gierula
@sl
type
label
John Gierula
@ast
John Gierula
@en
John Gierula
@en-gb
John Gierula
@es
John Gierula
@nl
John Gierula
@sl
prefLabel
John Gierula
@ast
John Gierula
@en
John Gierula
@en-gb
John Gierula
@es
John Gierula
@nl
John Gierula
@sl
P184
P106
P21
P213
0000 0004 6421 7954
P31
P496
0000-0001-9588-191X